Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04787848 · ClinicalTrials.gov registry record · NA
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
A NA study of Chronic Widespread Pain, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04787848 is a NA study of Chronic Widespread Pain that is actively recruiting participants, run by Florida International University. The registered enrollment target is 200 participants, above the 45-participant average among 4 other Chronic Widespread Pain trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04787848, a NA study of Chronic Widespread Pain, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
Conditions Studied
Interventions
- DRUG Relistor Injectable Product
Study Locations (1)
Florida
- Ambulatory Care Center, Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04787848
The ClinicalTrials.gov registry entry for NCT04787848 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 4 other Chronic Widespread Pain trials with a reported enrollment target (344% higher). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Widespread Pain appearing as the primary indexed condition, and to 1 intervention - of which Relistor Injectable Product is the first listed.
NCT04787848 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04787848 about?
NCT04787848 is a clinical study titled "Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics". To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
What is the current status of trial NCT04787848?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-11-15. Estimated completion is 2026-07-30.
What conditions does trial NCT04787848 study?
This clinical trial studies the following conditions: Chronic Widespread Pain.
What interventions are being tested in trial NCT04787848?
The interventions under investigation include: Relistor Injectable Product (DRUG).
Who is sponsoring clinical trial NCT04787848?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04787848 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Widespread Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
RECRUITING · NA
-
Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain
ACTIVE NOT RECRUITING · NA
-
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
COMPLETED · NA
-
Two Point Discrimination
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.